Goldman Sachs expects Nvidia ’beat and raise,’ lifts price target to $240
Investing.com -- Johnson & Johnson has experienced a 17% increase in lawsuits alleging its talc-based baby powder causes cancer after a court rejected the company’s latest settlement attempt.
According to securities filings released last week, J&J now faces approximately 73,570 lawsuits from consumers who claim the product caused their illnesses, up from about 62,830 suits reported in December 2024.
The mounting legal challenges come after the company’s most recent effort to reach a global settlement was dismissed in bankruptcy court. J&J discontinued its talc-based baby powder in 2023, replacing it with a cornstarch alternative.
Despite the growing number of claims, the pharmaceutical giant maintains that talc does not cause cancer and that its baby powder never contained asbestos. The company also asserts it has marketed the product appropriately throughout its more than 100-year history.
J&J has stated it will not pay more than the $9 billion it offered during the previous bankruptcy proceedings to resolve the litigation.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.